Cymabay Therapeutics Inc sell Midas
Start price
12.02.21
/
50%
€4.80
Target price
12.02.22
-
Performance (%)
-36.21%
End price
25.08.21
€3.06
Summary
This prediction ended on 25.08.21 with a price of €3.06. Midas correctly predicted massive losses of -36.21% for Cymabay Therapeutics Inc. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cymabay Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -0.420% | 2.791% | 23.151% | 88.659% |
| iShares Nasdaq 100 | 0.946% | 3.064% | 15.831% | 93.528% |
| iShares Nikkei 225® | 5.808% | 8.752% | 17.018% | 53.400% |
| iShares S&P 500 | 0.608% | 2.070% | 8.306% | 60.154% |
Comments by Midas for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Sell Cymabay Therapeutics Inc